Rocky Mountain Pharmacy Inc, Bozeman, MT

Is Rocky Mountain Pharmacy Inc registered with the FDA as a 503B outsourcing facility?

No matching record found in FDA’s registered outsourcing facility list (updated Nov 6, 2026) on Nov 15, 2026, searching by name and location. FDA’s compounding inspections and actions page labels it a 503A facility.

Does Rocky Mountain Pharmacy Inc hold a Montana pharmacy license?

State board of pharmacy records for Montana are not checked: this index has not yet added that board’s records.

Has Rocky Mountain Pharmacy Inc had a state board action or FDA letter?

FDA letters: record found. FDA’s compounding inspections and actions page, current as of Oct 22, 2026, lists 1 warning letter (May 9, 2019), 1 warning letter close-out (Mar 16, 2022), 1 state handoff letter (Mar 16, 2022) and 1 FMD-145 letter (Mar 18, 2022) for Rocky Mountain Pharmacy Inc. State board of pharmacy records for Montana are not checked: this index has not yet added that board’s records. The state referral and handoff letters above are FDA’s letters to the state, not board actions.

FDA registers 503B outsourcing facilities; state boards of pharmacy license pharmacies, including 503A compounding pharmacies, and keep their own disciplinary records. Neither FDA list says which drugs a pharmacy makes.

Names in FDA records
Rocky Mountain Pharmacy Inc
Location
Bozeman, MT
Type as FDA labels it
503A
FDA 503B list
No matching record found
Form 483s on FDA’s actions page
0
Warning letters on FDA’s actions page
1
Latest action on that page
Mar 18, 2022
FDA Data Dashboard inspections
No matching site found
State board records
Not checked

FDA inspections and letters

FDA’s compounding inspections and actions page (current as of Oct 22, 2026) lists this pharmacy as Rocky Mountain Pharmacy Inc, a 503A facility, with 4 dated actions.

Document
Mar 18, 2022FMD-145 letterFMD-145 Letter Issued 03/18/2022Not linked by FDA
Mar 16, 2022State handoff letterState Handoff Letter Issued 03/16/2022Not linked by FDA
Mar 16, 2022Warning letter close-outWarning Letter Close Out Issued 03/16/2022Not linked by FDA
May 9, 2019Warning letterWarning Letter (05/09/2019)FDA copy (archived)

A warning letter states FDA’s view when it was issued, not a court finding; any close-out letter FDA lists is a row of its own. An untitled or FMD-145 letter states FDA’s view when it was issued.

FDA inspection classifications and published Form 483s

No inspected site under this exact name and city was found in the FDA Data Dashboard on Nov 15, 2026, searching 12,593 US sites with a drug inspection ending Oct 1, 2008 to Oct 23, 2026. FDA may list the site under another legal name, so this is not a finding that it was never inspected.

State board of pharmacy records

State board of pharmacy records for Montana are not checked: this index has not yet added that board’s records.

This page restates FDA’s lists. A Form 483, letter or board action is not a finding by this site, and a missing record is not a finding either way. A state license is matched only on the same name, city and state. Follow each link for the original document. Report an error or add a company response.

Sources

Records last pulled Nov 15, 2026. Every entry links to the original public record.